Circulating aberrant plasma cells allows risk stratification of patients with myeloma

Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24.

Authors

Affiliations

¹ Hematology Service, Hospital Rafael Méndez, Lorca.
² Immunology Service, Instituto Murciano de investigación biosanitaria (IMIB) and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd), Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA).
³ Hematology Service, HCUVA.
⁴ Hematology Service, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain.

PMID: 27220360
DOI: 10.1002/ajh.24431

No abstract available

Keywords: FISH; circulating aberrant plasma cells; flow cytometry; myeloma; risk stratification.

Publication types

Letter